FACT Capital’s Boston Scientific BSX Stock Holding History

FACT Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-95,907	Closed	-$9.14M	–	18
2025 Q4	$9.14M	Hold	95,907	–	–	5.11%	11
2025 Q3	$9.36M	Sell	95,907 -48,065	-33%	-$4.98M	4.87%	11
2025 Q2	$15.5M	Sell	143,972 -14,907	-9%	-$1.51M	7.35%	7
2025 Q1	$16M	Hold	158,879	–	–	7.61%	3
2024 Q4	$14.2M	Sell	158,879 -21,567	-12%	-$1.9M	6.19%	6
2024 Q3	$15.1M	Sell	180,446 -47,923	-21%	-$3.78M	5.86%	8
2024 Q2	$17.6M	Sell	228,369 -13,750	-6%	-$1.01M	6.27%	7
2024 Q1	$16.6M	Hold	242,119	–	–	6.03%	5
2023 Q4	$14M	Sell	242,119 -16,880	-7%	-$901K	5.61%	9
2023 Q3	$13.7M	Sell	258,999 -41,965	-14%	-$2.2M	5.43%	9
2023 Q2	$16.3M	Hold	300,964	–	–	7.59%	6
2023 Q1	$15.1M	Sell	300,964 -2,667	-0.9%	-$126K	8.13%	6
2022 Q4	$14M	Buy	+303,631	New	+$13.1M	8.17%	6

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FACT Capital's BSX Position: Q1 2026 in Review

FACT Capital sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 95,907 shares — an estimated $9.14M sold.

FACT Capital first reported a position in BSX in Q4 2022 and held it in 13 quarters. The position peaked at $17.6M in Q2 2024. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

FACT Capital reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
FACT Capital sold 95,907 Boston Scientific shares in Q1 2026, an estimated $9.14M.
FACT Capital first reported a position in Boston Scientific in Q4 2022 and held it in 13 quarters.
FACT Capital's Boston Scientific position peaked at $17.6M in Q2 2024.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on FACT Capital's 13F filing for Q1 2026, filed 15 May 2026.